In non-small-cell lung cancer, the most prevalent type of lung cancer, a specific mutated gene was identified. Two enzymes suppress this gene since they do not work properly; leading to tumor growth and inflammation. These two enzymes have the most potent effect in suppressing tumors.
The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered ...
In non-small-cell lung cancer, the most prevalent type of lung cancer, a specific mutated gene was identified. Two enzymes suppress this gene since they do not work properly; leading to tumor growth and inflammation. These two enzymes have the most potent effect in suppressing tumors.
The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered ...